True Percutaneous Approach for Transfemoral Aortic Valve Implantation Using the Prostar XL Device

Hayashida, Kentaro; Lefèvre, Thierry; Chevalier, Bernard; Hovasse, Thomas; Romano, Mauro; Garot, Philippe; Mylotte, Darren; Uribe, Jhonathan; Farge, Arnaud; Donzeau–Gouge, Patrick; Bouvier, Erik; Cormier, Bertrand; Morice, Marie‐Claude

doi:10.1016/j.jcin.2011.09.020

Cited by 108 publications

(85 citation statements)

References 29 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Moreover, early experience has previously been identified as a risk factor for vascular complications. 20 Therefore, large-scale studies are essential to investigate the feasibility and safety of this technique in small slightly-built Japanese patients.…”

Section: Discussionmentioning

confidence: 99%

Thirty-Day Outcome of Transcatheter Aortic Valve Implantation With the Edwards SAPIEN XT Prosthesis via the Transiliofemoral Approach

Fuku

Goto

Komiya

et al. 2014

Circ J

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

Thirty-Day Outcome of Transcatheter Aortic Valve Implantation With the Edwards SAPIEN XT Prosthesis via the Transiliofemoral Approach

Fuku

Goto

Komiya

et al. 2014

Circ J

View full text Add to dashboard Cite

“…Before TAVI, 1 ml/kg/h of 0.9% NaCl solution was administered for 24 h to the patients with a GFR <50 ml/min/1.73 m 2 ; 48-72 h after the TAVI operation, 0.5 mg/dl or a 25% increase compared to the basal creatinine value was defined as CIN [11,15,16,17,18,19,20]. Our study was conducted in accordance with the Declaration of Helsinki, and the study protocol was approved by the local ethics committee.…”

Section: Methodsmentioning

confidence: 99%

The Importance of Contrast Volume/Glomerular Filtration Rate Ratio in Contrast-Induced Nephropathy Patients after Transcatheter Aortic Valve Implantation

et al. 2014

View full text Add to dashboard Cite

Background/Aim: Transcatheter aortic valve implantation (TAVI) is a method which is increasingly applied in severe aortic stenosis treatment. The development of contrast-induced nephropathy (CIN) after TAVI increases morbidity and mortality rates. Within the scope of this study, the importance of the contrast medium volume to glomerular filtration rate (CV/GFR) ratio in determining the development of CIN and the amount of CV that could be applied was evaluated. Methods: Seventy-two patients (aged 78.6 ± 11.6 years; 38 females) who underwent aortic valve replacement with the TAVI method between June 2013 and August 2014 were included in the study. CIN was defined as an absolute increase in serum creatinine of >0.5 mg/dl or a relative increase of >25% within 48-72 h after TAVI. CIN+ and CIN- patients were classified into two groups. The χ² test, t test, Mann-Whitney U test, ROC analysis, and univariate and multivariate regression analyses were applied for statistical analyses. Results: CIN was detected in 16 patients (22%) in our study. Baseline creatinine, baseline GFR, the Mehran risk score, CV, and the CV/GFR ratio were determined as the predictive factors of CIN development. A CV/GFR ratio of 3.9 was specified to predict CIN development with 71% sensitivity and 80% specificity. Conclusion: After TAVI, CIN may develop due to various reasons. In patients to whom TAVI was applied, the CV/GFR ratio may be a guideline helping to prevent the development of renal pathologies. The amount of contrast medium that can be given to a patient can be calculated in terms of baseline GFR.

show abstract

“…An awareness of potential harm with check angiography and 'cross-over' access from the contralateral side has improved safety in this regard. The current evidence is that the use of VCDs has a learning curve and in experienced hands they are effective, reduce complications and are likely to influence early mobility and discharge of TAVI patients [16,17].…”

Section: Vascular Injurymentioning

confidence: 99%

Trans-catheter aortic valve implantation: Contemporary practice and the future

2017

View full text Add to dashboard Cite

show abstract

True Percutaneous Approach for Transfemoral Aortic Valve Implantation Using the Prostar XL Device

Abstract: Experience reduced major vascular complications in a true percutaneous approach for transfemoral-TAVI. Further application of this less invasive strategy is feasible and may be beneficial, in this high-risk patient cohort.

Cited by 108 publications

References 29 publications

Thirty-Day Outcome of Transcatheter Aortic Valve Implantation With the Edwards SAPIEN XT Prosthesis via the Transiliofemoral Approach

Thirty-Day Outcome of Transcatheter Aortic Valve Implantation With the Edwards SAPIEN XT Prosthesis via the Transiliofemoral Approach

The Importance of Contrast Volume/Glomerular Filtration Rate Ratio in Contrast-Induced Nephropathy Patients after Transcatheter Aortic Valve Implantation

Trans-catheter aortic valve implantation: Contemporary practice and the future

Contact Info

Product

Resources

About